Stockreport

IBD Stock Of The Day: Genetics Firm Breaks Out On Cancer Testing Trends [Investor's Business Daily]

Myriad Genetics, Inc.  (MYGN) 
Last myriad genetics, inc. earnings: 2/6 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: myriad.com/news-center/investor-information
PDF Related news Myriad Genetics ( MYGN ) is the IBD Stock Of The Day after it broke out Wednesday on an analyst upgrade noting trends in genetic cancer tests are improving [Read more]